netFormulary Portsmouth and South East Hampshire NHS
Prescribing Formulary  
 Search
 Results

Looking for Adalimumab found 27 matches

Formulary items 4 matches
   
Formulary BNF Category
  Adalimumab  (Humira® Imraldi® Amgevita®)
(injection )
Cytokine inhibitors - 01.05.03
  Adalimumab  (Imraldi ® Amgevita ® Humira ®)
(injection )
Drugs affecting the immune response - 10.01.03
  Adalimumab injection  (Imraldi ® Amgevita ® Humira®) Other anti-inflammatory preparations - 11.04.02
  Adalimumab injection  (Imraldi ® Amgevita ® Humira®) Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA 187 Infliximab and adalimumab for the treatment of Crohn’s disease (01.05.03)
link in drug section NICE TA 329 Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA 460 Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)
link in drug section NICE TA 460 Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.02)
link in drug section NICE TA146 Adalimumab for the treatment of adults with psoriasis (13.05.03)
link in drug section NICE TA187: Crohn’s disease - infliximab and adalimumab  (01.05.03)
link in drug section NICE TA187: Crohns disease - infliximab & adalimumab (01.05.03)
link in drug section NICE TA187: Crohns disease - infliximab & adalimumab (01.05.03)
link in subsection NICE TA199: Psoriatic arthritis - etanercept, infliximab and adalimumab (10.01.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis (01.05.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for JIA (10.01.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in drug section NICE TA373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis (10.01.03)
link in subsection NICE TA375: Rheumatoid arthritis - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept (10.01.03)
link in drug section NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa (13.05.03)


 

netFormulary